Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Trimi Health vs Shape Vantage

Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Shape Vantage a 44. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Trimi Health

#3 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Trimi Health review →
VS

Shape Vantage

#390 · Grade C · Watch List

Est. first month

From $599/mo (compounded)

Save ~56% vs brand-name
Get this deal Full Shape Vantage review →

The verdict

Better value: Trimi Health

Trimi Health takes it on Value Score, 89 to 44 an est. $99/mo first month, with no teaser step-up baked in. Shape Vantage isn't out of it: Shoppers who want transparency listing only — LOW confidence, not recommended.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealTrimi HealthShape Vantage
Value Score89 (A)44 (C)
Est. first month$99/moFrom $599/mo (compounded)
Save vs brand-name~93%~56%
Semaglutide$99/moNot disclosed
Tirzepatide$125/moFrom $599/mo (compounded)
Both moleculesYesNo
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
20
Trimi Health: 95. Shape Vantage: 20.
84
No Teaser-Rate Bait
72
Trimi Health: 84. Shape Vantage: 72.
98
Nationwide Availability
45
Trimi Health: 98. Shape Vantage: 45.
94
Both Molecules
62
Trimi Health: 94. Shape Vantage: 62.
82
Easy Cancellation
58
Trimi Health: 82. Shape Vantage: 58.
70
Reputation
25
Trimi Health: 70. Shape Vantage: 25.

Trimi Health

The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.

Why it's a deal

  • Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
  • Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
  • Nationwide 50-state reach, so the low price isn't gated to a handful of states

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
  • Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
  • Newer brand with a thin public track record

Shape Vantage

Shape Vantage is a tirzepatide reseller with a hybrid grey-market profile that does not match the typical compounded-telehealth model.

Why it's a deal

  • $599 product price shown publicly, not gated behind intake
  • Terms of Service exists and discloses the legal relationship
  • Positions itself as 'Premium Weight Loss Treatment'

The fine print

  • Homepage uses a dietary-supplement-style disclaimer, not language seen on legitimate prescription products
  • Links straight to a Stripe checkout with no medical intake, consultation, or prescription gate
  • Terms reserve the option to ship without prescription or provider review where not legally required
  • No LegitScript, NABP, state-pharmacy, or PCAB accreditation visible
  • Legal entity and state of incorporation not disclosed (only California governing law)
Get the Trimi Health deal Get the Shape Vantage deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Shape Vantage.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.